Research Paper Advance Articles

Identification of prognostic long non-coding RNA signature with potential drugs in hepatocellular carcinoma

Kaplan–Meier analysis showing the OS- and RFS-time expectancy. (A–C) The overall survival curves of HCC patients in training, validation and whole cohorts grouped by the risk level. (D–F) The relapse-free survival curves of HCC patients in training, validation and whole cohorts grouped by the risk level.

Figure 5. Kaplan–Meier analysis showing the OS- and RFS-time expectancy. (AC) The overall survival curves of HCC patients in training, validation and whole cohorts grouped by the risk level. (DF) The relapse-free survival curves of HCC patients in training, validation and whole cohorts grouped by the risk level.